Prescription ID | TCMF1982 |
Pinyin Name | Chong Cao Bu Tian Jing |
Chinese Name | 虫草补天精 |
English Name | Oral Liquid of Cordyceps |
Function Description | |
Indications | None |
Disease ICD-11 Category | |
Human Tissues Associated with Indication | |
Reference | Chinese Classical Prescriptions |
Reference Book/link | ISBN 7-5023-3930-2 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH743 | Plastrum testudinis | 龟板 | TCMH743 | |
TCMH494 | Cordyceps sinensis | 冬虫夏草 | TCMH494 | AF291749 |
TCMH1186 | Lycium chinense | 枸杞子 | TCMH1186 | ITSAO4545-14 |
TCMH1966 | Rehmannia glutinosa | 熟地黄 | TCMH1966 | ITSAH4578-14 |
TCMH981 | Astragalus membranaceus | 黄芪 | TCMH981 | ITSAK2981-14 |
TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
TCMH2162 | Lac regis apis | 王浆 | TCMH2162 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
TCMT290 | CHRM5 | Muscarinic acetylcholine receptor M5 | GPCR | P08912 |
TCMT291 | CHRM3 | Muscarinic acetylcholine receptor M3 | GPCR | P20309 |
TCMT292 | CHRM1 | Muscarinic acetylcholine receptor M1 | GPCR | P11229 |
TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT632 | PNP | Purine nucleoside phosphorylase | Transferase | P00491 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT683 | MIF | Macrophage migration inhibitory factor | Isomerase | P14174 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT907 | FDPS | Farnesyl diphosphate synthase | Lyase | P14324 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
Target ID | Target Name |
---|---|
TCMT1178 | Actinomyces viscosus |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1207 | Legionella pneumophila |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1212 | Verticillium dahliae |
TCMT1218 | Staphylococcus aureus |
TCMT1221 | Human herpesvirus 4 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 13.8974 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 12.7687 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FDPS, FUT7, MIF, PPARA, XDH | 9.8057 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FABP3, FABP4, FDPS, FUT7, HSD17B1, MIF, PPARA | 7.49044 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA | 6.99732 |
[BP] GO:0007197 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.85422 |
[BP] GO:0007207 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.40582 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 6.04029 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA | 5.8902 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.8902 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, FDPS, HSD17B1 | 5.67268 |
[BP] GO:0007213 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.53953 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF | 4.34559 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FDPS, FUT7, MIF, PPARA | 4.30338 |
[BP] GO:0006690 | icosanoid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF | 4.21855 |
[BP] GO:0019369 | arachidonic acid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 4.1605 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 | 4.14541 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 | 4.10279 |
[BP] GO:0095500 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.03329 |
[BP] GO:1903831 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.03329 |
[BP] GO:0006631 | fatty acid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA | 3.95732 |
[BP] GO:0007271 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.79341 |
[BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.79341 |
[BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.79341 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FUT7, HSD17B1, MIF, MMP1, MMP2, MMP9, PPARA, XDH | 3.65436 |
[BP] GO:0007193 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 | 3.55994 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, XDH | 3.55994 |
[BP] GO:1901568 | fatty acid derivative metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF | 3.39391 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FUT7, HSD17B1, MIF, MMP1, MMP2, PPARA, XDH | 3.37409 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.35599 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD17B1 | 3.35599 |
[BP] GO:0007200 | None | CHRM1, CHRM2, CHRM3, CHRM5, ESR1 | 3.3426 |
[BP] GO:0006811 | None | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM5, FABP3, PPARA | 3.07953 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 3.06405 |
[BP] GO:0009115 | None | AOX1, XDH | 2.8239 |
[BP] GO:0032787 | None | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA | 2.62084 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA | 2.55756 |
[BP] GO:0009725 | response to hormone | AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, PPARA | 2.52401 |
[BP] GO:0006940 | None | ADORA1, CHRM1, CHRM2, CHRM3 | 2.44981 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CHRM5, CYP1A1, FABP3, FDPS, HCAR2, PPARA | 2.44981 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, MMP2, MMP9, PPARA | 2.44981 |
[BP] GO:0046110 | None | AOX1, XDH | 2.40211 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.40211 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.33306 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, XDH | 2.32404 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1 | 2.29233 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.29233 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD17B1, MIF | 2.24272 |
[BP] GO:0007188 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 | 2.24272 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 | 2.20507 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, PPARA | 2.20507 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, HCAR2, HSD17B1, MIF, PPARA, XDH | 2.19576 |
[BP] GO:0022900 | electron transport chain | AKR1B1, AOX1, CYP19A1, CYP1A2, XDH | 2.18958 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, CHRM1, CSNK2A1, CYP1B1, ESR1, ESRRA, FABP3, MIF, MMP2, MMP9, XDH | 2.18935 |
[BP] GO:0006145 | None | AOX1, XDH | 2.18935 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.18935 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.18935 |
[BP] GO:0044070 | regulation of anion transport | ADORA1, CA2, CA7, MIF | 2.16443 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA | 2.16443 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA | 2.07171 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, MMP2, PPARA | 2.07021 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7 | 2.00542 |
[BP] GO:0046541 | None | CHRM1, CHRM3 | 2.00542 |
[BP] GO:0007187 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 | 2.00542 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9, CHRM3 | 1.97604 |
[CC] GO:0032279 | None | CHRM2, CHRM3 | 1.6522 |
[CC] GO:0043679 | None | CHRM1, CHRM2, CHRM3 | 1.4583 |
[CC] GO:0045202 | None | ACHE, CHRM1, CHRM2, CHRM3, CHRM5 | 1.44482 |
[CC] GO:0098984 | None | CHRM2, CHRM3 | 1.43604 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 19.3184 |
[MF] GO:0046914 | transition metal ion binding | AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, XDH | 16.4714 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 12.9581 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.6949 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA | 9.04928 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 7.88091 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 7.49044 |
[MF] GO:0043169 | cation binding | ACHE, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FDPS, MMP1, MMP2, MMP9, PPARA, XDH | 6.90409 |
[MF] GO:0016907 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.85422 |
[MF] GO:0043167 | ion binding | ACHE, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, HSD17B1, MMP1, MMP2, MMP9, PPARA, XDH | 6.12763 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 | 5.8902 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FDPS, FUT7, HSD17B1, MIF, MMP1, MMP2, MMP9, XDH | 5.80046 |
[MF] GO:0005506 | iron ion binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH | 5.78636 |
[MF] GO:0046872 | metal ion binding | AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FDPS, MMP1, MMP2, MMP9, PPARA, XDH | 5.6801 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 | 4.4546 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 4.37 |
[MF] GO:0015464 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.36267 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA | 4.33782 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA | 4.33782 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA | 4.02247 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 3.79341 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 3.63761 |
[MF] GO:0004629 | None | ADORA1, CHRM1, CHRM3, CHRM5 | 3.63761 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, XDH | 3.4891 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6 | 3.44665 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 3.39391 |
[MF] GO:0005496 | steroid binding | ESR1, ESR2, ESRRA, ESRRB, HSD17B1 | 3.35599 |
[MF] GO:0099528 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.30968 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, XDH | 3.02284 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, XDH | 2.91296 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.8239 |
[MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.8239 |
[MF] GO:0008227 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 2.64856 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, ESRRA, ESRRB, HCAR2, PPARA | 2.20507 |
[MF] GO:0004435 | None | CHRM1, CHRM3, CHRM5 | 2.18935 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.18935 |
[MF] GO:0008081 | None | ADORA1, CHRM1, CHRM3, CHRM5 | 2.00542 |
[MF] GO:0030284 | estrogen receptor activity | ESR1, ESR2 | 2.00542 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 21.0997 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD17B1, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 5.4499 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1 | 5.0693 |
Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, ACHE, CHRM3, CHRM1, CHRM5 | 4.4484 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, AOX1, CYP1B1 | 4.7183 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1 | 4.9129 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | HSD17B1, CYP1A1, CYP1B1, CYP19A1 | 4.4484 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 5.4695 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1, AOX1 | 4.0411 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, CHRM3, CHRM1, ADORA3, CHRM5, ADORA1 | 3.7807 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.9834 |
cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, HCAR2, CHRM1, ADORA1, PPARA | 3.4492 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | MMP2, MMP9, ESR1, ESR2 | 3.4492 |
Metabolic pathways_Homo sapiens_hsa01100 | FDPS, CYP2A6, FUT7, HSD17B1, CYP1A2, CYP1A1, AOX1, AKR1B1, CYP19A1, XDH | 2.9983 |
Bladder cancer_Homo sapiens_hsa05219 | MMP1, MMP2, MMP9 | 3.3098 |
Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2, CHRM3, CHRM1, CHRM5 | 2.5974 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, CYP1A2, AOX1 | 2.694 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, CHRM3, CHRM1, CHRM5 | 2.3562 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | MMP2, MMP9, ESR1 | 1.5176 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1 | 1.6544 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | ESR1, ESR2 | 1.4814 |
Gastric acid secretion_Homo sapiens_hsa04971 | CHRM3, CA2 | 1.4764 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, XDH | 1.8011 |
Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, MIF | 2.014 |
Pancreatic secretion_Homo sapiens_hsa04972 | CHRM3, CA2 | 1.2949 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, ADORA1 | 1.1449 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 1.1449 |
Pathways in cancer_Homo sapiens_hsa05200 | MMP1, MMP2, MMP9 | 0.9183 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1 | 0.9263 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 2.3562 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | CYP1B1, MMP9 | 0.6556 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, CHRM1 | 0.6242 |
Taste transduction_Homo sapiens_hsa04742 | CHRM3 | 0.6242 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2 | 0.6121 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.6242 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.6409 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.6556 |
Insulin secretion_Homo sapiens_hsa04911 | CHRM3 | 0.6242 |
GnRH signaling pathway_Homo sapiens_hsa04912 | MMP2 | 0.6242 |
Adherens junction_Homo sapiens_hsa04520 | CSNK2A1 | 0.6332 |
Salivary secretion_Homo sapiens_hsa04970 | CHRM3 | 0.6242 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B1 | 0.6784 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.6242 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.6242 |
Bile secretion_Homo sapiens_hsa04976 | CA2 | 0.6409 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.6242 |
Insulin resistance_Homo sapiens_hsa04931 | PPARA | 0.5926 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.5926 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.6121 |
Measles_Homo sapiens_hsa05162 | CSNK2A1 | 0.5345 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.5345 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | ESR1 | 0.5724 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1 | 0.6229 |
Hepatitis B_Homo sapiens_hsa05161 | MMP9 | 0.5302 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.6218 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | ESRRB | 0.5345 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1 | 0.5345 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.5237 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1 | 0.5345 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | AOX1 | 0.513 |
Influenza A_Homo sapiens_hsa05164 | FDPS | 0.4856 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1 | 0.4536 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.4856 |
HTLV-I infection_Homo sapiens_hsa05166 | FDPS | 0.376 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.7533 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | MMP9 | 0.4832 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.4791 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.7533 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B1 | 0.8955 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | CYP1A2 | 0.8983 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B1 | 0.852 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.8931 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.8983 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B1 | 0.8908 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.9076 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.9045 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | FDPS | 0.9385 |
Phenylalanine metabolism_Homo sapiens_hsa00360 | MIF | 1.034 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.4192 |